Impact of grafted serotonin and dopamine neurons on development of L-DOPA-induced dyskinesias in parkinsonian rats is determined by the extent of dopamine neuron degeneration.
about
Foetal Cell Transplantation for Parkinson's Disease: Focus on Graft-Induced DyskinesiaStem cell transplantation therapy in Parkinson's diseaseFunctional neuroimaging in Parkinson's diseaseCell fate analysis of embryonic ventral mesencephalic grafts in the 6-OHDA model of Parkinson's diseaseStem cells in human neurodegenerative disorders--time for clinical translation?Pedunculopontine nucleus deep brain stimulation in Parkinson's disease.Optimized adeno-associated viral vector-mediated striatal DOPA delivery restores sensorimotor function and prevents dyskinesias in a model of advanced Parkinson's diseasePresynaptic dopaminergic compartment determines the susceptibility to L-DOPA-induced dyskinesia in ratsOptimizing the success of cell transplantation therapy for stroke.Dopamine release from serotonergic nerve fibers is reduced in L-DOPA-induced dyskinesia.Differential dopamine receptor occupancy underlies L-DOPA-induced dyskinesia in a rat model of Parkinson's diseaseStriatal activation by optogenetics induces dyskinesias in the 6-hydroxydopamine rat model of Parkinson disease.Cyclosporin promotes neurorestoration and cell replacement therapy in pre-clinical models of Parkinson's diseaseNeurorehabilitation with neural transplantation.Understanding graft-induced dyskinesia.Cell-based therapies for Parkinson's disease.Cellular programming and reprogramming: sculpting cell fate for the production of dopamine neurons for cell therapy.The serotonergic system in motor and non-motor manifestations of Parkinson's disease.L-DOPA and graft-induced dyskinesia: different treatment, same story?Directed midbrain and spinal cord neurogenesis from pluripotent stem cells to model development and disease in a dish.The potential of alternate sources of cells for neural grafting in Parkinson's and Huntington's disease.A PITX3-EGFP Reporter Line Reveals Connectivity of Dopamine and Non-dopamine Neuronal Subtypes in Grafts Generated from Human Embryonic Stem Cells.A Subpopulation of Dopaminergic Neurons Coexpresses Serotonin in Ventral Mesencephalic Cultures But Not After Intrastriatal Transplantation in a Rat Model of Parkinson's Disease.SERT-to-DAT ratios in early Parkinson's disease do not correlate with the development of dyskinesiasLocal Change in Urinary Bladder Contractility Following CNS Dopamine Denervation in the 6-OHDA Rat Model of Parkinson's Disease.Role of Serotonin Neurons in L-DOPA- and Graft-Induced Dyskinesia in a Rat Model of Parkinson's Disease.Understanding and prevention of "therapy-" induced dyskinesias.Proceedings: cell therapies for Parkinson's disease from discovery to clinic.Serotonergic neurons mediate dyskinesia side effects in Parkinson's patients with neural transplants.Cell Therapy for Parkinson's Disease.Graft-induced dyskinesias fail to respond to 5HT1A agonist in the long-term.Regenerative therapy in experimental parkinsonism: mixed population of differentiated mouse embryonic stem cells, rather than magnetically sorted and enriched dopaminergic cells provide neuroprotection.
P2860
Q26765499-98751088-533E-429F-B3E8-B23309F55660Q26778682-CE979891-A313-485F-9941-F6FA8374012EQ27013767-9414C1E1-FE81-407D-83D4-AD352D134119Q27334576-D824AC59-340B-47F1-B6F1-1E110CDC166EQ27687068-B7C8ABDF-761A-4774-B95D-D244F7BDB49BQ30471148-9B681B5E-C0D2-45E5-910B-402A585C214DQ30493158-05C9B3B9-8F9D-4A4E-8420-BBF3FA9560C1Q33628372-1F8BD417-5F82-496D-AE57-8BB202E5D0C8Q33636930-E4A5FE18-53D9-452B-98E3-59E2E0448DA7Q35038040-D52060CB-C259-4F45-AA93-453933DBCBBEQ35116470-6DFC0884-80B0-4E71-9A1F-4C361AA7DA8FQ36296271-69365858-006A-4802-BF10-BCBEB4C5A217Q36370618-372DA380-FA9F-425B-B2CE-49CE649607D1Q37774495-69A086B7-6387-424C-9551-60C81C56F1D8Q37792121-0376AFEF-A286-4431-A474-83085036CBB6Q37886149-0523F810-593D-4F59-A31D-554C461149B4Q38044388-DEA43602-FA90-4B8A-A4A4-73745C7B2289Q38118061-73374589-8D0A-48D1-9CD5-EDF6ED9F2AB8Q38119449-CD63C341-42B0-4B77-B122-9AC91ABE7F0CQ38218082-40889531-D5F0-4E1A-8AD1-EB907163E49FQ38260092-05AE6F0D-DB47-49F0-A016-88163BB1987AQ38693456-6EAA25FD-AEB8-47E8-82C5-D7AE459D6A02Q38784743-59EA01FB-B68A-42DF-A8A4-6D808B5D6E78Q39407055-13900A33-7E2A-4008-9253-24155E0FFCC4Q41387301-77DBF9C6-FFC3-4AEA-9122-C46A5C5C29E9Q41853023-ABB8ABE5-322E-4324-AB49-873143EFBC64Q42052125-51076352-856F-46CB-8688-6A19168D9A1DQ42545361-34BDB434-1C0F-4D31-80A1-5E001CD912BEQ42997555-8593B870-0DFC-4D69-954F-2BF63E21ADA1Q45740164-F11BC63A-7B44-4CC8-B06D-2AFA77B32F38Q48287510-EFBA1D73-158F-4B6B-83CB-5DCC0DD7234EQ48703357-8AA50B6E-668F-4D34-8BEB-79F3EACF6448
P2860
Impact of grafted serotonin and dopamine neurons on development of L-DOPA-induced dyskinesias in parkinsonian rats is determined by the extent of dopamine neuron degeneration.
description
2008 nî lūn-bûn
@nan
2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Impact of grafted serotonin an ...... dopamine neuron degeneration.
@ast
Impact of grafted serotonin an ...... dopamine neuron degeneration.
@en
type
label
Impact of grafted serotonin an ...... dopamine neuron degeneration.
@ast
Impact of grafted serotonin an ...... dopamine neuron degeneration.
@en
prefLabel
Impact of grafted serotonin an ...... dopamine neuron degeneration.
@ast
Impact of grafted serotonin an ...... dopamine neuron degeneration.
@en
P2093
P50
P921
P356
P1433
P1476
Impact of grafted serotonin an ...... dopamine neuron degeneration.
@en
P2093
Bengt Mattsson
Christian Winkler
Deniz Kirik
P304
P356
10.1093/BRAIN/AWN305
P407
P577
2008-11-27T00:00:00Z